Carl June of the Perelman School of Medicine is featured for his role in a personalized cellular therapy cancer treatment developed with Stephen Grupp of the Children’s Hospital of Philadelphia. The treatment has been approved by the Food and Drug Administration.

August 30, 2017 ・ From The New York Times